English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

COVID-19 vaccination during pregnancy associated with reduced risk of preeclampsia

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Danish study finds no increased death risk from menopausal hormone therapy

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Study links ANGPTL4 deficiency during development to reduced colitis risk in mice

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Cochrane review finds limited benefit of Ginkgo biloba for mild cognitive impairment

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Analysis finds most English regions fall short on safe GP staffing levels

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Researchers outline risks linked to widely used diabetes and weight-loss drugs

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Positrigo introduces program to expand access to brain PET imaging in U.S. neurology offices

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Boomerang Ventures invests in IMPOWER HEALTH; appoints Trent McCracken as CEO

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones

  • « First
  • «
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily